ERP - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 88221611
Serial Number
88221611
Registration Number
6137043
Word Mark
ERP
Status
700 - Registered
Status Date
2020-08-25
Filing Date
2018-12-07
Registration Number
6137043
Registration Date
2020-08-25
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2019-10-22
Attorney Name
Susan J. Brushaber
Law Office Assigned Location Code
M80
Employee Name
MEYERS, MORGAN LAURA
Statements
Goods and Services
Pharmaceutical preparations for medical purposes for blood system disorders, cardiac disorders, connective tissue disorders, endocrine disorders, immune system disorders, metabolism and nutrition disorders, neoplasms, nervous system disorders, pregnancy, puerperium and perinatal disorders, skin and subcutaneous tissue disorders, vascular disorders; plasma for treatment of blood system disorders, cardiac disorders, connective tissue disorders, endocrine disorders, immune system disorders, metabolism and nutrition disorders, neoplasms, nervous system disorders, pregnancy, puerperium and perinatal disorders, skin and subcutaneous tissue disorders, vascular disorders; diagnostic and therapeutic preparations for medical or veterinary use, in particular preparations produced using molecular biological, biotechnological and genetic methods; surgical implants grown from stem cells; stem cells for medical purposes; pharmaceutical preparations for stem cell transplantation, therapy and research; pharmaceutical and veterinary preparations for treatment of blood system disorders, cardiac disorders, connective tissue disorders, endocrine disorders, immune system disorders, metabolism and nutrition disorders, neoplasms, nervous system disorders, pregnancy, puerperium and perinatal disorders, skin and subcutaneous tissue disorders, vascular disorders; sanitary preparations for medical purposes; blood plasma; reagents for medical purposes; medical diagnostic reagent; biological preparations for medical purposes used in the treatment of blood system disorders, cardiac disorders, connective tissue disorders, endocrine disorders, immune system disorders, metabolism and nutrition disorders, neoplasms, nervous system disorders, pregnancy, puerperium and perinatal disorders, skin and subcutaneous tissue disorders, vascular disorders; chemical preparations for pharmaceutical purposes, namely, chemical preparations for blood system disorders, cardiac disorders, connective tissue disorders, endocrine disorders, immune system disorders, metabolism and nutrition disorders, neoplasms, nervous system disorders, pregnancy, puerperium and perinatal disorders, skin and subcutaneous tissue disorders, vascular disorders; diagnostic preparations for medical purposes; pharmaceutical products for the treatment of blood system disorders, cardiac disorders, connective tissue disorders, endocrine disorders, immune system disorders, metabolism and nutrition disorders, neoplasms, nervous system disorders, pregnancy, puerperium and perinatal disorders, skin and subcutaneous tissue disorders, vascular disorders
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-12-31
Primary Code
005
First Use Anywhere Date
2019-11-01
First Use In Commerce Date
2019-11-01
Current Trademark Owners
Party Name
Mononuclear Therapeutics Limited
Party Type
30 - Original Registrant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Mononuclear Therapeutics Limited
Party Type
30 - Original Registrant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Mononuclear Therapeutics Limited
Party Type
20 - Owner at Publication
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Mononuclear Therapeutics Limited
Party Type
10 - Original Applicant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Susan J. Brushaber
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2018-12-11NEW APPLICATION ENTERED IN TRAM
2018-12-31NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2019-03-06ASSIGNED TO EXAMINER
2019-03-13NON-FINAL ACTION WRITTEN
2019-03-13NON-FINAL ACTION E-MAILED
2019-03-13NOTIFICATION OF NON-FINAL ACTION E-MAILED
2019-09-12TEAS RESPONSE TO OFFICE ACTION RECEIVED
2019-09-12CORRESPONDENCE RECEIVED IN LAW OFFICE
2019-09-13TEAS/EMAIL CORRESPONDENCE ENTERED
2019-09-14APPROVED FOR PUB - PRINCIPAL REGISTER
2019-09-18ASSIGNED TO LIE
2019-09-25TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2019-09-25ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2019-10-02NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2019-10-22PUBLISHED FOR OPPOSITION
2019-10-22OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2019-12-17NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2020-01-29TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2020-01-29ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2020-06-17TEAS STATEMENT OF USE RECEIVED
2020-06-17TEAS EXTENSION RECEIVED
2020-07-01CASE ASSIGNED TO INTENT TO USE PARALEGAL
2020-06-17EXTENSION 1 FILED
2020-07-01EXTENSION 1 GRANTED
2020-06-17USE AMENDMENT FILED
2020-07-01STATEMENT OF USE PROCESSING COMPLETE
2020-07-02NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-07-22ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2020-07-23NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
2020-08-25REGISTERED-PRINCIPAL REGISTER